Serge Lepage

机构：Université de Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke · ORCID：0000-0002-4242-9740

发表论文 117 篇 · 总被引 4816 次 · h-index 29

代表论文

• CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021 · Canadian Journal of Cardiology · 被引 291)
• Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure (2023 · Journal of the American College of Cardiology · 被引 175)
• Global Variations in Heart Failure Etiology, Management, and Outcomes (2023 · JAMA · 被引 169)
• Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol (2021 · Journal of the American College of Cardiology · 被引 146)
• Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab (2022 · Circulation · 被引 126)
• Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 84)